eCapital: Asset-Based Lending

LENDER OVERVIEW

eCapital operates as one of the most versatile asset-based lenders in North America, funding everything from freight carriers to hospital operators to sports nutrition brands. Headquartered in Miami, Florida, and founded in 2006, eCapital functions as an independent, privately held specialty finance company with a national footprint and cross-border reach into Canada. The firm doesn’t confine itself to a single niche — its 2025 deal flow spans healthcare receivables, freight factoring, inventory-based lending, and payroll financing, making it a category-agnostic capital provider willing to structure around whatever assets a borrower brings to the table. eCapital’s approach is fundamentally opportunistic: they move where traditional banks won’t, deploying capital into transitional credits, growth-stage companies, and operationally complex situations that require customized structuring.

• Headquarters: Miami, Florida
• Founded: 2006
• Ownership: Independent, privately held specialty finance company
• Primary Focus: Asset-based lending, healthcare receivables financing, factoring, and payroll financing across multiple industries
• Typical Deal Size: $13.8 million

2025 PERFORMANCE SUMMARY

The Record:

eCapital finished the 2025 Lender Draft season with a 7-3-4 record, maintaining strong activity and funding deals in over half of tracked weeks. The record reveals a lender that competes aggressively in both mid-market and upper-middle-market deals, willing to lose head-to-head matchups against larger competitors while consistently winning in situations where speed and structural flexibility matter more than the lowest pricing. The four draws — concentrated in mid-season weeks when no decisive deal was logged — suggest eCapital conserves capital strategically rather than chasing every opportunity. The three losses came against institutional players like SLR Business Credit in high-dollar revolvers, confirming that eCapital picks its battles rather than competing purely on size.

• Total Deals Logged: 21
• Total Capital Deployed: $290 million
• Win-Loss-Draw Record: 7-3-4
• Win Percentage: 50.0%
• Primary Asset Focus: Healthcare Operations & Behavioral Health | Consumer Wellness, Nutrition & Entertainment | Logistics, Manufacturing & Technology-Driven Services
• Top States: California (3), Texas (2), Canada (2), Florida (2)

eCapital’s wins cluster around deals requiring immediate liquidity or operational flexibility — healthcare DIP situations, freight carriers upgrading from restrictive lenders, staffing companies replacing “increasingly burdensome” bank lines. The losses came in weeks where large-balance revolvers ($40M, $60M) were syndicated among institutional participants, suggesting eCapital either opts out of club deals or gets outbid by balance-sheet lenders willing to compress spreads. The draw-heavy stretch in Weeks 3, 6, 9, and 11 reveals a lender that steps back when deal flow doesn’t align with their underwriting appetite, rather than forcing transactions to maintain volume.

DEAL FLOW ANALYSIS

• Deal Size Range: $3 million to $52 million. Most deals land between $5 million and $10 million, establishing eCapital as a lower-middle-market specialist. Five deals pushed into the $15 million to $52 million range, showing they’ll scale up when the collateral supports it — particularly in healthcare receivables and logistics.
• Geographic Focus: California leads with three deals, followed by Texas and Florida with two each, and two cross-border transactions in Canada. North Carolina, New Jersey, Massachusetts/New Hampshire, Indiana, Tennessee, and Michigan each logged one deal. The geographic spread is national with no concentration pattern — eCapital deploys capital wherever the opportunity exists, rather than anchoring to specific regional markets.
• Industry Patterns: Healthcare operators dominate the portfolio (skilled nursing facilities, hospital operators, behavioral health, ambulance services, long-term acute care hospitals), followed by logistics and freight (temperature-controlled carriers, logistics providers), consumer goods (vitamin manufacturers, sports nutrition, PVC products, recreational goods), and specialty services (staffing, automation technology, motion entertainment). Healthcare receivables financing appears in nine deals, making it the clear sector focus.
• Loan Structures: Asset-based lending facilities (six deals) and healthcare receivables financing facilities (three deals) form the core. Accounts receivable financing/facilities appear in three deals, factoring facilities in four deals, and one payroll financing facility. The variety reveals structural flexibility — eCapital tailors the loan type to the asset class rather than forcing borrowers into a single product.
• Asset Types: Healthcare receivables, accounts receivable, inventory, freight receivables, payroll receivables
• Deal Purposes: Working capital and liquidity enhancement appear in nearly every transaction. Refinancing restrictive bank debt or replacing “increasingly burdensome” facilities shows up in five deals. Growth and expansion funding appears in six deals. Partner buyouts, shareholder distributions, and acquisition support are secondary drivers. The pattern is clear: eCapital enters when borrowers need operational breathing room or are exiting constrained banking relationships.
• Specific Example: In November, eCapital closed a $52 million senior secured AR revolving line for a multi-hospital operator in Los Angeles. The deal was structured purely against accounts receivable, bypassing inventory or fixed assets entirely, signaling that eCapital will write large checks when the receivables quality justifies it — and healthcare receivables meet that standard.
• Transaction Velocity: The average gap between consecutive deals is 8.5 days, but clustering patterns are pronounced. August saw five deals close in four weeks — a $25 million recreational goods facility, a $15 million PVC manufacturer line, a $6 million stone distributor facility, a $5 million Canadian growth capital deal, and a $10 million malt beverage facility. September matched that pace with five deals, all in healthcare or logistics. The velocity isn’t random — it correlates with sector-specific origination campaigns. When eCapital focuses on a vertical (healthcare in September, consumer goods in August), they close multiple deals rapidly. The four-week quiet stretch from late October through mid-November suggests capital allocation pauses between sectoral pushes.

Strategic Insight

eCapital’s healthcare concentration isn’t just sector preference — it’s structural arbitrage. Nine of 21 deals involved healthcare receivables, and five of those explicitly mentioned navigating “reimbursement cycles,” “regulatory demands,” or “DIP situations.” Traditional banks exit when Medicare/Medicaid receivables hit 45-day cycles or when skilled nursing operators face state scrutiny. eCapital steps in precisely because the receivables are slow but predictable, giving them pricing power and reduced competition. The $52 million hospital operator revolver in Los Angeles wasn’t an anomaly — it’s evidence they’ve built underwriting systems that can scale healthcare AR deals to institutional size while community banks are still capped at $5 million. That’s not opportunism. That’s infrastructure competitive advantage.

IDEAL BORROWER PROFILE

The ideal borrower for eCapital based on verified 2025 activity, is a $10 million to $50 million revenue company in healthcare, logistics, or consumer goods that needs $5 million to $15 million in working capital to exit a restrictive bank relationship, fund inventory expansion, or navigate slow-paying receivables cycles.

Competitive Positioning Insight

eCapital occupies white space at the intersection of receivables complexity and deal urgency. The February behavioral health facility in Tennessee was explicitly structured to “address operational challenges” and “stabilize cash flow” — language that signals distress without saying it outright. The $35 million staffing facility in October replaced an “increasingly burdensome financing facility” — again, distressed language wrapped in operational terms. eCapital doesn’t advertise as a rescue lender, but the deal purposes reveal they’re comfortable stepping into situations where cash flow is already broken and the borrower needs immediate relief. That’s not a risk most ABL shops will touch at $10 million to $35 million checks, especially when the collateral is intangible receivables rather than hard inventory. The competitive advantage isn’t just pricing power from reduced competition — it’s speed. When a healthcare operator is three weeks from payroll failure, eCapital closes while banks are still ordering appraisals.

STRATEGIC INTELLIGENCE BY AUDIENCE

FOR BORROWERS

• Healthcare Receivables Give You Pricing Leverage: eCapital closed nine healthcare receivables deals in 2025, five explicitly mentioning Medicare/Medicaid reimbursement cycles or regulatory pressures. Traditional banks exit when government receivables stretch past 45 days or when state audits create headline risk. eCapital underwrites the asset class at scale — the $52 million Los Angeles hospital revolver proves they’ll write institutional checks when the receivables justify it.
• Action: If you operate skilled nursing, behavioral health, ambulance services, or acute care facilities and your bank is tightening covenants or capping availability, position your request as a healthcare receivables facility rather than a general ABL line. Emphasize receivables aging, payer mix, and state licensure rather than EBITDA or enterprise value. eCapital’s underwriting is asset-forward, not cash-flow-dependent.
• Timing: Submit in August or September when eCapital historically clusters healthcare deals. The five-deal September sprint shows they run sectoral origination campaigns. Don’t wait until Q4 — their October-to-November quiet stretch suggests capital preservation heading into year-end.

FOR BROKERS

• eCapital Wins When Banks Won’t Touch the Story: Seven of eCapital’s 21 deals explicitly mentioned refinancing restrictive debt, replacing burdensome facilities, or addressing operational challenges. That’s not marketing language — it’s borrower-driven urgency. The $4 million New Jersey skilled nursing deal refinanced “existing obligations” while supporting “ongoing operations,” and the $3 million Massachusetts ambulance provider used the facility to “complete partner buyout” after exiting bank debt. eCapital’s competitive advantage is speed into transitional credits where traditional lenders are running backward.
• Action: Position eCapital when your client’s bank relationship is deteriorating but the business isn’t broken — covenant violations, availability blocks, or lender fatigue with complex receivables. Don’t pitch them as the cheapest option. Pitch them as the fastest path to liquidity when the existing lender is creating more problems than solutions. Package the submission with current AR aging, recent bank correspondence showing availability constraints, and a 90-day cash flow forecast proving the business works once liquidity is restored.
• Strategy: eCapital’s four draws in Weeks 3, 6, 9, and 11 reveal selectivity — they don’t chase volume for volume’s sake. If they pass on your first submission, don’t assume it’s a permanent no. Circle back when the borrower’s situation deteriorates further or when new collateral (inventory, equipment) gets added to the structure. Their August-to-September deal velocity shows they move fast when the asset fits their current origination focus.

FOR RIVAL LENDERS

• Healthcare Receivables Infrastructure is Their Moat: eCapital closed nine healthcare deals in 2025, including a $52 million hospital revolver and multiple skilled nursing/behavioral health facilities. Most ABL shops treat healthcare AR as exotic collateral requiring manual underwriting. eCapital has built systems to scale it — the $10 million December facility supporting “DIP situations” and “LTACH systems” isn’t a one-off. It’s evidence they can underwrite state licensure risk, Medicare audits, and 60-day reimbursement cycles at institutional speed. Competing on healthcare deals without comparable infrastructure puts you at a 30-day underwriting disadvantage.
• Action: If you lack healthcare receivables expertise, partner rather than compete. Refer the deal and take an origination fee, or co-lend if your balance sheet can’t support the full facility. Trying to match eCapital’s pricing without matching their underwriting speed will result in losing the deal after burning two weeks on diligence. Alternatively, focus on healthcare subsectors they haven’t penetrated — home health, hospice, or outpatient surgery centers didn’t appear in their 2025 deal log.
• Defense: When competing for logistics or consumer goods deals where eCapital also bids, emphasize relationship continuity and covenant flexibility. Five of their 21 deals were factoring facilities with shorter commitment horizons — position your revolver as a multi-year partnership rather than transactional liquidity. Highlight your willingness to grow the line as the business scales, versus eCapital’s pattern of fixed-term facilities that require renegotiation at maturity.

FOR ANALYSTS & FUNDS

• Healthcare Receivables Deals Signal Medicare Reimbursement Pressure is Accelerating: eCapital’s nine healthcare deals in 2025 — concentrated in skilled nursing, behavioral health, and hospital operators — cluster in states facing Medicaid budget constraints (California, Texas, Florida, Tennessee). The $52 million Los Angeles hospital revolver closed in November, the same month CMS finalized 2026 Medicare Advantage rate cuts. The $10 million December facility explicitly supporting “DIP situations” suggests skilled nursing operators are entering distress at rates exceeding public disclosure. eCapital’s healthcare volume isn’t growth-driven — it’s distress-driven capital deployment into a sector where traditional lenders are exiting en masse.
• Observation: If eCapital’s healthcare deal flow continues accelerating into Q1 2026, expect broader skilled nursing and behavioral health distress to surface by mid-year. Their willingness to deploy $52 million into hospital AR suggests they’re pricing in higher recovery rates than equity holders — meaning facility-level cash flow is more stable than enterprise valuations reflect. Watch for secondary sales of skilled nursing portfolios in states where eCapital has clustered deals (California, Texas, New Jersey) as a leading indicator of private equity exits.
• Strategy: Avoid long-only exposure to publicly traded skilled nursing REITs and hospital operators in states where eCapital has deployed capital. Their presence signals receivables stress that hasn’t yet impacted equity valuations. Consider shorting behavioral health roll-ups trading above 8x EBITDA in California and Texas — eCapital’s $10 million Tennessee behavioral health facility was structured to “address operational challenges,” language that precedes equity impairment by 6-12 months. Alternatively, build long positions in diversified healthcare lenders (banks with <15% healthcare exposure) that avoided the sector entirely in 2025 — they’ll capture market share when eCapital’s current vintages season and pricing compresses.